octimibate has been researched along with epoprostenol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brassard, CL; Buchanan, JO; Federici, ME; Fleming, JS; Gamberdella, M; Meanwell, NA; Rosenfeld, MJ; Trehan, AK; Wright, JJ; Zavoico, GB | 1 |
| Brassard, CL; Buchanan, JO; Gougoutas, JZ; Malley, MF; Martin, SW; Meanwell, NA; Romine, JL; Rosenfeld, MJ; Trehan, AK; Wright, JJ | 1 |
2 other study(ies) available for octimibate and epoprostenol
| Article | Year |
|---|---|
Nonprostanoid prostacyclin mimetics. 2. 4,5-Diphenyloxazole derivatives.
Topics: Adenosine Diphosphate; Cell Membrane; Humans; Oxazoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Structure-Activity Relationship | 1992 |
Nonprostanoid prostacyclin mimetics. 5. Structure-activity relationships associated with [3-[4-(4,5-diphenyl-2-oxazolyl)-5- oxazolyl]phenoxy]acetic acid.
Topics: Acetates; Adenosine Diphosphate; Binding, Competitive; Crystallization; Epoprostenol; Humans; Hydrogen Bonding; Iloprost; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Molecular Structure; Oxazoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Epoprostenol; Receptors, Prostaglandin; Structure-Activity Relationship | 1993 |